Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunwei Shen

Showing results (61-70 of 207) with videos related to

Pageof 21
Sort By:
Frontiers in Immunology|February 13, 2025
Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancerShuwen Dong, Anqi Li, Ruixin Pan, et al.
Scientific Reports|April 29, 2020
Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer PatientsLifen Cai, Yiwei Tong, Xiaoping Zhu, et al.
BMC Cancer|February 22, 2023
Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expressionQin Shi, Jing Yu, Deyue Liu, et al.
Gland Surgery|November 29, 2023
Tumor size is associated with adjuvant chemotherapy benefit in T1N0M0 triple-negative breast cancer: a multicenter and propensity score matched analysisChenghui Wu, Ou Huang, Jiayi Wu, et al.
Oncotargets and Therapy|June 11, 2021
Identification of Ten Mitosis Genes Associated with Tamoxifen Resistance in Breast CancerXi Sun, Shuning Ding, Shuangshuang Lu, et al.
Journal of Cancer Research and Therapeutics|April 14, 2016
Concurrent adjuvant radiochemotherapy versus standard chemotherapy followed by radiotherapy in operable breast cancer after breast conserving therapy: A meta-analysisOu Huang, Dandan Wu, Li Zhu, et al.
International Immunopharmacology|September 18, 2021
Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancerShuning Ding, Xi Sun, Li Zhu, et al.
Journal of Cancer|March 12, 2019
Clinical validation of Ki67 by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in HR+/HER2- early breast cancerWeiqi Gao, Jiayi Wu, Xiaosong Chen, et al.
International Journal of Molecular Sciences|January 8, 2025
The Biological Roles and Clinical Applications of the PI3K/AKT Pathway in Targeted Therapy Resistance in HER2-Positive Breast Cancer: A Comprehensive ReviewHanyi Zhong, Ziling Zhou, Han Wang, et al.
Frontiers in Oncology|December 21, 2020
Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based StudyDeyue Liu, Jiayi Wu, Caijin Lin, et al.
Pageof 21

Showing results (61-70 of 207) with videos related to

Sort By:
Pageof 21
Frontiers in Immunology|February 13, 2025
Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancerShuwen Dong, Anqi Li, Ruixin Pan, et al.
Scientific Reports|April 29, 2020
Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer PatientsLifen Cai, Yiwei Tong, Xiaoping Zhu, et al.
BMC Cancer|February 22, 2023
Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expressionQin Shi, Jing Yu, Deyue Liu, et al.
Gland Surgery|November 29, 2023
Tumor size is associated with adjuvant chemotherapy benefit in T1N0M0 triple-negative breast cancer: a multicenter and propensity score matched analysisChenghui Wu, Ou Huang, Jiayi Wu, et al.
Oncotargets and Therapy|June 11, 2021
Identification of Ten Mitosis Genes Associated with Tamoxifen Resistance in Breast CancerXi Sun, Shuning Ding, Shuangshuang Lu, et al.
Journal of Cancer Research and Therapeutics|April 14, 2016
Concurrent adjuvant radiochemotherapy versus standard chemotherapy followed by radiotherapy in operable breast cancer after breast conserving therapy: A meta-analysisOu Huang, Dandan Wu, Li Zhu, et al.
International Immunopharmacology|September 18, 2021
Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancerShuning Ding, Xi Sun, Li Zhu, et al.
Journal of Cancer|March 12, 2019
Clinical validation of Ki67 by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in HR+/HER2- early breast cancerWeiqi Gao, Jiayi Wu, Xiaosong Chen, et al.
International Journal of Molecular Sciences|January 8, 2025
The Biological Roles and Clinical Applications of the PI3K/AKT Pathway in Targeted Therapy Resistance in HER2-Positive Breast Cancer: A Comprehensive ReviewHanyi Zhong, Ziling Zhou, Han Wang, et al.
Frontiers in Oncology|December 21, 2020
Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based StudyDeyue Liu, Jiayi Wu, Caijin Lin, et al.
Pageof 21